Levonorgestrel/Ethinylestradiol Eugia (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol/Levonorgestrel, the active ingredient in Levonorgestrel/Ethinylestradiol Eugia, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Levonorgestrel/Ethinylestradiol Eugia as a licensed, GDP‑compliant international pharmaceutical supplier, providing reliable sourcing to hospitals, pharmacies and clinics worldwide, with adherence to EU quality standards and export regulations. The product is manufactured under EU GMP guidelines and is available for bulk and unit‑dose orders.

Levonorgestrel/Ethinylestradiol Eugia, a combined oral contraceptive, is used to prevent pregnancy.

Contraception: prevents pregnancy in women of childbearing potential. Menstrual cycle regulation: helps establish regular menstrual cycles. Acne improvement: may reduce acne associated with androgen excess.

Levonorgestrel/Ethinylestradiol Eugia may cause a range of adverse reactions.

Common Side Effects: - Nausea or vomiting - Breast tenderness or enlargement - Headache - Weight gain or fluid retention - Mood changes - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension - Hepatic adenoma or other liver disorders - Anaphylaxis or severe allergic reaction - Visual disturbances or eye pain

Before prescribing Levonorgestrel/Ethinylestradiol Eugia, clinicians should consider several safety factors.

Contraindication: known or suspected pregnancy. Risk assessment: personal or family history of thromboembolic disease. Smoking: avoid use in women over 35 who smoke. Medication review: avoid concomitant use with strong enzyme‑inducing drugs. Medical conditions: uncontrolled hypertension, active liver disease, or diabetes with vascular complications. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Levonorgestrel/Ethinylestradiol Eugia can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine) may reduce contraceptive effectiveness. - Anticoagulants may increase risk of thrombosis when combined with hormonal contraception. - Certain antifungal agents (e.g., itraconazole) can raise hormone levels, increasing side‑effect risk.

Moderate Interactions (Monitor Closely): - SSRIs may alter bleeding patterns. - Antihypertensive agents may have altered blood pressure control. - Herbal supplements such as St. John’s wort may diminish contraceptive efficacy.